Crystal structure of a prostate kallikrein isolated from stallion seminal plasma: a homologue of human PSA.
暂无分享,去创建一个
Juan J Calvete | Antonio Romero | J. Calvete | L. Sanz | M. Romão | A. Carvalho | A. Romero | Ana L Carvalho | Maria J Romão | Libia Sanz | Domingo Barettino | D. Barettino
[1] B. Gibbs,et al. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I. , 1997, Biochemistry.
[2] D. Chan,et al. Concentration of enzymatically active prostate‐specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models , 2001, The Prostate.
[3] R. Freidinger,et al. A peptide–doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo , 2000, Nature Medicine.
[4] P. Cuasnicú,et al. Potential contraceptive use of epididymal proteins: immunization of male rats with epididymal protein DE inhibits sperm fusion ability. , 1998, Biology of reproduction.
[5] M. Maruyama,et al. Prostate‐specific antigen activates single‐chain urokinase‐type plasminogen activator , 1995, International journal of cancer.
[6] G. Bricogne,et al. [27] Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. , 1997, Methods in enzymology.
[7] U. Stenman,et al. Measurement of the complex between prostate-specific antigen and alpha1-protease inhibitor in serum. , 1999, Clinical chemistry.
[8] D. Timm. The crystal structure of the mouse glandular kallikrein‐13 (prorenin converting enzyme) , 1997, Protein science : a publication of the Protein Society.
[9] O. Nilsson,et al. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. , 1991, Clinical chemistry.
[10] D. Corey,et al. Substrate specificity of prostate-specific antigen (PSA). , 1998, Chemistry & biology.
[11] M. James,et al. Rat submaxillary gland serine protease, tonin. Structure solution and refinement at 1.8 A resolution. , 1987, Journal of molecular biology.
[12] A. Tulinsky,et al. The refinement and the structure of the dimer of alpha-chymotrypsin at 1.67-A resolution. , 1985, The Journal of biological chemistry.
[13] R M Esnouf,et al. Further additions to MolScript version 1.4, including reading and contouring of electron-density maps. , 1999, Acta crystallographica. Section D, Biological crystallography.
[14] H. Lilja,et al. Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen. , 1996, Urology.
[15] Robert M. Stroud,et al. Design of potent selective zinc-mediated serine protease inhibitors , 1998, Nature.
[16] G J Barton,et al. ALSCRIPT: a tool to format multiple sequence alignments. , 1993, Protein engineering.
[17] P. Vihko,et al. Prostate-specific antigen and human glandular kallikrein: two kallikreins of the human prostate. , 1994, Annals of medicine.
[18] M. Barry. Prostate-Specific–Antigen Testing for Early Diagnosis of Prostate Cancer , 2001 .
[19] B Honig,et al. Computer simulations of the diffusion of a substrate to an active site of an enzyme. , 1987, Science.
[20] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[21] Eleftherios P. Diamandis,et al. The New Human Kallikrein Gene Family: Implications in Carcinogenesis , 2000, Trends in Endocrinology & Metabolism.
[22] Anastassis Perrakis,et al. Automated protein model building combined with iterative structure refinement , 1999, Nature Structural Biology.
[23] M. Pollak,et al. Insulin-like Growth Factors and Prostate Cancer , 2001, Cancer and Metastasis Reviews.
[24] L. Ashworth,et al. Molecular Cloning of the Human Kallikrein 15 Gene (KLK15) , 2001, The Journal of Biological Chemistry.
[25] J. Oesterling,et al. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. , 1991, The Journal of urology.
[26] Takanori Nakamura,et al. The chymotrypsin‐like activity of human prostate‐specific antigen, γ‐seminoprotein , 1987 .
[27] J L Sussman,et al. Specific chemical and structural damage to proteins produced by synchrotron radiation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[28] G. Sheldrick,et al. SHELXL: high-resolution refinement. , 1997, Methods in enzymology.
[29] A. Tulinsky,et al. Comparison of the independent solvent structures of dimeric alpha-chymotrypsin with themselves and with gamma-chymotrypsin. , 1985, The Journal of biological chemistry.
[30] L. Giudice,et al. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. , 1992, The Journal of clinical endocrinology and metabolism.
[31] W. Bode,et al. Refined 2 A X-ray crystal structure of porcine pancreatic kallikrein A, a specific trypsin-like serine proteinase. Crystallization, structure determination, crystallographic refinement, structure and its comparison with bovine trypsin. , 1983, Journal of molecular biology.
[32] J. Calvete,et al. Purification, crystallization and identification by X-ray analysis of a prostate kallikrein from horse seminal plasma. , 2001, Acta crystallographica. Section D, Biological crystallography.
[33] R J Fletterick,et al. X-ray structures of a designed binding site in trypsin show metal-dependent geometry. , 1996, Biochemistry.
[34] U. Stenman,et al. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. , 1991, Cancer research.
[35] M. Vihinen. Modeling of prostate specific antigen and human glandular kallikrein structures. , 1994, Biochemical and biophysical research communications.
[36] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[37] E A Merritt,et al. Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.
[38] H. Lilja,et al. Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa. , 1989, The Journal of biological chemistry.
[39] H. Bartunik,et al. Crystal structure of bovine beta-trypsin at 1.5 A resolution in a crystal form with low molecular packing density. Active site geometry, ion pairs and solvent structure. , 1989, Journal of molecular biology.
[40] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[41] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[42] B. Cooperman,et al. Inhibition of prostate-specific antigen (PSA) by alpha(1)-antichymotrypsin: salt-dependent activation mediated by a conformational change. , 2002, Biochemistry.
[43] M. Webber,et al. Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[44] E. Diamandis. Prostate-specific antigen: a cancer fighter and a valuable messenger? , 2000, Clinical chemistry.
[45] T. Marti,et al. Isolation, characterization and amino-acid sequence of gamma-seminoprotein, a glycoprotein from human seminal plasma. , 1987, European journal of biochemistry.
[46] P. Kraulis. A program to produce both detailed and schematic plots of protein structures , 1991 .
[47] B. Katz,et al. Development of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor Xa. , 2001, Journal of medicinal chemistry.
[48] H. Lilja,et al. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. , 1990, European journal of biochemistry.
[49] R. Wolfert,et al. "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia. , 2000, Urology.
[50] M. Raida,et al. Biochemical and conformational characterisation of HSP‐3, a stallion seminal plasma protein of the cysteine‐rich secretory protein (CRISP) family , 1997, FEBS letters.
[51] E. Getzoff,et al. A structural model for the prostate disease marker, human prostate‐specific antigen , 1994, Protein science : a publication of the Protein Society.
[52] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[53] M. Papa,et al. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. , 1993, The Journal of clinical endocrinology and metabolism.
[54] E. Diamandis. Sequencing with microarray technology--a powerful new tool for molecular diagnostics. , 2000, Clinical chemistry.